FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 273 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Robin Williams Required Film Companies He Worked With To Hire Homeless... November 25, 2021 ‘Levelling Up’: What should it mean for cancer? February 2, 2022 Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and... April 14, 2026 Osimertinib Shows Promising Activity in Previously Untreated Patients with Metastatic NSCLC... December 19, 2023 Load more HOT NEWS FDA Approves Enfortumab Vedotin-ejfv with Pembrolizumab for Locally Advanced or Metastatic... Experts Propose a Clinical Definition of Acquired Resistance to PD-(L)1 Blockade... More Than One in 10 Patients With Lung Cancer Do Not... Foodie Friday: Couscous Salad
